Emergent BioSolutions’ (EBS) “Buy” Rating Reaffirmed at HC Wainwright
Emergent BioSolutions (NYSE:EBS – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a research report issued on Tuesday,Benzinga reports. They presently have a $15.00 price target on the biopharmaceutical company’s stock. HC Wainwright’s target price suggests a potential upside of 189.58% from the company’s previous close. Separately, […]
Emergent BioSolutions (NYSE:EBS – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a research report issued on Tuesday,Benzinga reports. They presently have a $15.00 price target on the biopharmaceutical company’s stock. HC Wainwright’s target price suggests a potential upside of 189.58% from the company’s previous close. Separately, […]
